Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Eddy Blinker who wrote (1558)	11/9/1999 5:20:00 PM
From: Bo Didley	Respond to of 5582

This is my interpretation GUMM investors are in for the long term and keep buying. Shorts have moved in for a quick trade but can't compete with the long termer's who won't sell and keep buying. There is no reason to sell and all the reasons to buy when you know GUMM will have fabulous earnings numbers for years to come. Growth of Zicam entering the $2.5 Billion OTC cold remedy market is extremely exiting! We are invested in the future, not traders for a few pennies. We are invested to become multi-millionaires, and we're not interested in just a few points up. GUMM is a very long term investment. bo